Dr. Katherine Gordon

Katherine Gordon is a biotech and life science entrepreneur with extensive background identifying promising early stage technologies and taking these forward into the commercial setting through startups and alliances with industry. She works as strategic advisor to seed investors and management, operating at interface of academia, hospitals and industry. Over 13 years at Harvard and Brown, Katherine worked to augment innovation and entrepreneurship, enhance partnerships with affiliated hospitals and industry, and commercialize research discoveries, as Director of Business Development and Managing Director. Previously, Katherine was the Founder and CEO of Apollo Biopharmaceutics, a biotech startup that developed novel neuroprotective products for the treatment of Alzheimer’s disease. Katherine was also Associate Director at Genzyme, where she was the co-inventor of technology to produce pharmaceutical proteins in animal milk, a discovery that led to an approved novel pharmaceutical product. Dr. Gordon has a PhD in Molecular Biology from Wesleyan University and a BSc in Biology with a minor in Biochemistry from Simon Fraser University. She had a post-doctoral fellowship at Yale University.